Aim: The parvalbumin (PV)-containing subgroup of GABAergic neurons is particularly affected in schizophrenia and animal models of psychosis, including after METH administration. We investigated whether METH dependence and METH-induced psychosis may involve an effect on DNA methylation of the PVALB promoter.
Introduction
Methamphetamine (METH), an amphetamine derivative, is a potent psychostimulant and highly addictive drug of abuse. Long term use of METH can result in the emergence of psychosis in a substantial proportion of users, the symptoms of which may be indistinguishable from schizophrenia [1, 2] . Acutely, METH causes an increase in dopamine release, which is likely to underlie several of its behavioural effects including the development of drug dependence [3] . In the longer term the drug can have neurotoxic effects on several neurotransmitter systems, including that of GABA [4, 5] . This has recent support both from pharmacogenetic studies of association between METH psychosis and polymorphisms in the GABA synthetic enzyme glutamate decarboxylase (GAD) genes [6] and from findings, in an animal model of METH abuse, of deficits in, most strongly, the parvalbumin (PV)-containing subtype of GABergic neurons in frontal cortex and hippocampus [7] .
Previous studies have provided substantial evidence for a dysfunction of inhibitory GABAergic interneurons in schizophrenia [8] [9] [10] . This is primarily reflected in deficits in PV-containing neurons in the frontal cortex [10] and, particularly, the hippocampus [11] . Enduring deficits of PV are also found in several animal models of schizophrenia, including after sub-chronic administration of the psychotogenic drug phencyclidine [12] .
Changes in GABA-related proteins may be regulated by the epigenetic control of gene expression [13] . DNA methylation of cytosine at CpG sequences can influence transcription factor binding to gene promoter sequences and is one epigenetic factor that can be modified by environmental factors, including drugs, and may well contribute to drug dependence [14] . A previous study has shown an increase in DNA methylation in the pvalb gene promoter in mouse hippocampus after manganeseinduced neuronal damage [15] . We have hypothesized that effects on DNA methylation of the PVALB promoter region might reduce PV expression and relate to the PV deficits in schizophrenia and models of psychosis, and recently reported that hypermethylation at one site of the equivalent Pvalb gene promoter sequence was observed in rat prefrontal cortex and hippocampus after phencyclidine administration [16] .
The present study aimed to investigate whether there was a change in methylation in the promoter sequence of the PVALB gene in DNA isolated from blood samples taken from subjects with METH dependence or METH-dependent psychosis. Pyrosequence programme set up and reading were performed using PyroMark Q24 2.0.6.20
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software (Qiagen, UK).
Statistical analysis
The statistical analysis employed SPSS 17.0 (SPSS Inc., USA). The primary analysis was to test for a difference in methylation across the four CpG sites between the METH and control groups. Secondary exploratory analyses were undertaken to determine if any effect was primarily in the METH psychosis group, and to investigate differences at the individual CpG sites. Statistical differences between groups were identified initially by multivariate ANOVA; secondary analyses employed univariate ANOVA. The correlation of DNA methylation with age was measured by Pearson correlation. The methylation results are expressed as % mean±SD.
Results
The percentage methylation across the four CpG sites in the sample groups is shown in Figure 3 
Discussion
These results revealed that DNA methylation of a sequence in the PVALB promoter region was significantly increased in METH dependence, with the effect primarily observed in subjects with a METH-induced psychosis. This finding was in the absence of any apparent effect on a global measure of DNA methylation, that of LINE-1. The correlation of methylation with age seen in the control group is an expected finding; a positive correlation with age is a common feature of DNA methylation [18] . The fact that this effect was lost in the METH group suggests that METH dependence has a disruptive effect on the normal control of DNA methylation in which a resultant hypermethylation masks the influence of age.
It seems likely that the PVALB hypermethylation in METH dependence is associated essentially with the emergence of psychosis, although the lack of statistical significance in the difference in methylation between the psychosis and non-psychosis subgroups means that we cannot be confident in drawing this conclusion.
It is not possible to ascribe a causal effect of METH dependence on this specific hypermethylation of PVALB in this cross-sectional study. While it is conceivable that individuals with higher levels of PVALB promoter methylation may be susceptible to METH-dependent psychosis, studies in animals suggest PVALB hypermethylation seems more likely to be a consequence rather than a cause of METH dependence. The observations that hypermethylation in equivalent sequences in the PV gene promoter of mice born to mothers following Mn-induced neurotoxicity [15] , and of rats previously undergoing a subchronic regime of phencyclidine administration [16] , both indicate that neuro-and psychoactive substances can have specific effects on PV gene methylation. In particular, the latter study and our findings both support an association between PV gene hypermethylation and psychosis, since phencyclidine administration is used as a model for some of the symptoms of schizophrenia.
An increase in PVALB methylation in METH dependent subjects may result in a reduction of PVALB gene and PV protein expressions. Previous studies showed that DNA hypermethylation is involved in suppressing expression of related genes whereas DNA hypomethylation is often related to gene over-expression [19] . Correlation between DNA hypermethylation of the serotonin transporter (5-HTT) promoter and the depletion in 5-HTT mRNA expression was found in the brain in schizophrenia [20] . An increase in brain-derived neurotrophic factor (BDNF) methylation is reportedly related to reductions in BDNF mRNA [21] . Therefore, it is conceivable that PVALB hypermethylation may result in diminished PV protein expression in schizophrenia and METHinduced psychosis. As mentioned above, animal models of both disorders, as well as human schizophrenia, show deficits in PV-expressing neurons, although a direct association between PV gene hypermethylation and diminished PV expression has yet to be demonstrated.
This study was only undertaken in male Thai subjects, reflecting the limited availability of samples and the sex distribution of METH abuse in the population. This limits the ability to extrapolate to female subjects and, inevitably, other ethnic groups, which needs to be addressed in further work. We recognize that the assessment of blood DNA, rather than DNA deriving from brain tissue, is another substantial but inevitable limitation to our study. However, previous work has demonstrated that hypermethylation of the 5-HTT promoter in saliva of schizophrenia patients paralleled changes in post-mortem brain [20] , and others have found concordant changes in methylation of DNA between blood lymphocytes and brain tissue [22] . Thus differences in DNA methylation in peripheral blood cell may well indicate differences in DNA methylation and its functional consequences in the brain.
Conclusion
This study revealed a significant increase in DNA methylation of the PVALB promoter in METH dependence, particularly METH-dependent subjects with psychosis. PVALB hypermethylation may well contribute to the reduction of PV protein expression previously reported in an animal model of METH abuse and to GABAergic system deficits in METH dependence. Furthermore, PVALB promoter hypermethylation may conceivably contribute to the PV deficits common both to models of psychosis and to human psychotic illness. This study was designed to determine whether there is abnormal DNA methylation of the PVALB promoter region in subjects with METH dependence and psychosis, as such an effect could contribute to diminished expression of PV.
Results
A significant increase in PVALB methylation was found in METH dependence and METH-induced psychosis. This finding was not associated with effects on a global measure of DNA methylation.
Conclusion
Our results show METH dependence and METH-induced psychosis are associated with PVALB hypermethylation. This specific increase in PVALB methylation may be a consequence of METH dependence and could conceivably contribute to deficits in PV expression that might in turn underlie METH-induced psychosis.
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